VEGFA and neoplasm: In addition, this treatment leads to an increase in ROS generation, ROS-mediated mitochondrial fragmentation, in the Ser15 phosphorylated p53 form and in the levels of many DNA damage markers, but a reduction in the expression level of VEGF and VEGF2, index of a decrease of tumor angiogenesis [167].